Novel mutation of early, perinatal-onset, myopathic-type very-long-chain acyl-CoA dehydrogenase deficiency
Seigo Korematsu1, Yujiro Kosugi, Toshihide Kumamoto
1Department of Pediatrics and Child Neurology, Faculty of Medicine, Oita University, Oita, Japan. kseigo@med.oita-u.ac.jp
Insights
This study reports a novel mutation causing myopathic-type very-long-chain acyl-CoA dehydrogenase deficiency in a neonate. Early diagnosis and management, including diet and avoiding fasting, led to normal development.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is a rare inherited metabolic disorder affecting fatty acid oxidation.
- Myopathic-type VLCAD deficiency typically presents with muscle weakness and exercise intolerance.
Observation:
- A male neonate experienced fetal distress, neonatal asphyxia, and transient hyper-creatine kinase-emia, followed by recurrent rhabdomyolysis.
- At age 6, the patient showed decreased serum carnitine levels and muscle abnormalities, with elevated 5-tetradecenoate in blood and serum.
- Skin fibroblast analysis revealed decreased acyl-CoA dehydrogenase activity and a compound heterozygote mutation in the ACADM gene (exons 9 and 10).
Findings:
- A novel compound heterozygote mutation (c.790A>G and c.997_998insT) in the ACADM gene was identified, causing myopathic-type very-long-chain acyl-CoA dehydrogenase deficiency.
- This mutation is associated with a perinatal onset, which has not been previously reported for this subtype.
- The patient's clinical presentation and biochemical findings were consistent with VLCAD deficiency.
Implications:
- This case highlights a novel mutation responsible for a severe form of VLCAD deficiency with perinatal onset.
- Effective management, including dietary modifications (high-carbohydrate, low-fat diet, avoiding fasting) and prompt treatment of rhabdomyolysis, can lead to normal physical and mental development.
- Early diagnosis and intervention are crucial for improving outcomes in patients with VLCAD deficiency.
Abstract:
A male neonate demonstrated fetal distress, neonatal asphyxia, and transient hyper-creatine kinase-emia (8400IU/L), followed by repeated episodes of rhabdomyolysis 1-2 times/year during infancy and early childhood. At age 6 years, decreased levels of total and free carnitine in serum, and mild fiber size variation and increased fatty droplets in muscle, were confirmed. Both blood and serum fatty-acid analysis demonstrated elevated 5-tetradecenoate levels, and the acyl-CoA dehydrogenase activity of the palmitoyl-CoA/octanoyl-CoA ratio decreased in skin fibroblasts. The sequenced clone analysis of a complimentary DNA fragment revealed a compound heterozygote mutation of exon 9 (A790G) and exon 10 (997 ins T), which is a novel mutation of a myopathic-type very-long-chain acyl-CoA dehydrogenase deficiency. The patient has reached age 13 years. By treatment with an avoidance of fasting, feeding with a high-carbohydrate and low-fat diet, and intravenous drip infusion soon after every onset of rhabdomyolysis, his physical and mental development has stayed within the normal range. Patients with a perinatal onset of myopathic-type very-long-chain acyl-CoA dehydrogenase deficiency have not yet been reported. His novel mutation might be related to his clinical characterization.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Animal Mitochondrial Genetics
Inborn Errors of Metabolism
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Huntington Disease l: Introduction
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
